Developer docs
API playgroundTry for free, no card

Search company profiles

Arrow Diagnostics

Full company profile

uuid0025atj

Namestring
Arrow Diagnostics
Legal namestring
Arrow Diagnostics S.r.l.
Company typeenum
Private
Founded yearint
2003
Descriptiontext

Arrow Diagnostics S.r.l. is an Italian molecular diagnostics distribution company headquartered in Genoa, founded in 2003 and operating as a wholly-owned subsidiary subject to the direction and coordination (direzione e coordinamento) of Seegene Inc., a South Korean molecular diagnostics group. The company is the exclusive Italian commercial arm of Seegene, distributing multiplex Real-Time PCR kits (Allplex, Anyplex, Novaplex brands), isothermal LAMP rapid tests (eazyplex), NGS solutions (AD4Seq, CleanPlex, Deeplex), rapid immunochromatographic tests (FREND), and fully automated instrumentation (Seegene STARlet, Seegene Nimbus, FACIS). The portfolio spans syndromic infectious disease testing (respiratory, gastrointestinal, STI, meningitis, antimicrobial resistance, mycobacteria, HPV, mycology), HIV drug resistance NGS, oncology (MammaTyper, MYELOID SOLUTION), and microbiome analysis.

Arrow Diagnostics generates revenue through the B2B sale of molecular diagnostic reagents, kits, and instrumentation to clinical hospital laboratories and public health institutions across Italy, supported by direct field sales coverage of Northern, Central, and Southern Italy and the major islands, plus regional technical representatives and applications support. Products are CE-IVD and IVDR-compliant where certified, with quote-based commercial terms and pricing not publicly disclosed. The company engages customers through scientific congresses (AMCLI, SIM, SIGU), peer-reviewed publications, technical webinars, and an Italian-language website providing IFU, SDS, and SSP documentation. Customer logos include hospital laboratories (e.g., Ospedale A.R.N.A.S. Civico di Cristina Benfratelli di Palermo, MATER OLBIA Hospital) and government/public bodies (ASL1 Imperiese, Lega Navale Italiana), with COVID-era event testing (Sanremo 2021, World Triathlon Cup, HANSA World Championship) representing episodic rather than recurring anchor revenue.

The company's strategic positioning is as a regulatory- and technically-capable local distributor that converts Seegene's global product cadence into Italy-specific clinical adoption, while coordinating Italian participation in parent-level initiatives including the Seegene-Microsoft AI collaboration, the Springer Nature Open Innovation Program, and the Werfen-Seegene technology-sharing JV. No independent venture capital, private equity investment, or public listing has been identified; the entity is fully owned and operated under Seegene's strategic direction.

Short descriptiontext

Arrow Diagnostics is the exclusive Italian distribution subsidiary of Seegene Inc., selling multiplex PCR kits, isothermal LAMP rapid tests, NGS solutions, and automation to clinical hospital laboratories and public health institutions across Italy.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersGenoa, Italy
HQ citystring
Genoa
HQ countrystring
Italy
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
molecular diagnostics distribution, multiplex real-time PCR, isothermal amplification tests, clinical microbiology reagents, next generation sequencing kits
Industry4 codes
PRIMARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAAALAL
Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)
SECONDARYHLAHAAAA
Clinical Chemistry & Immunoassay Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
NAICS code2 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Analytical Laboratory Instrument Manufacturing334516
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
Clinical Molecular Diagnostics
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Molecular Diagnostic Reagents and Kits
TypeHardware Sales
Description

Arrow Diagnostics generates revenue through the sale of molecular diagnostic reagents, PCR kits, and rapid test products to clinical laboratories, hospitals, and healthcare facilities in Italy. Products are sold directly to healthcare institutions with technical support services included.

arrowdiagnostics.it
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Arrow Diagnostics distributes and provides technical support for molecular diagnostic reagents, kits, and automated instrumentation in Italy on behalf of Seegene Inc. and other international diagnostic technology partners. Its core offering is a portfolio of multiplex Real-Time PCR assays (Allplex™, Anyplex™, Novaplex™), isothermal LAMP rapid tests (eazyplex®), NGS-based panels (AD4Seq, CleanPlex®, Deeplex®), chemiluminescence immunoassays, and supporting automated systems, sold directly to clinical hospital laboratories, public health labs, and healthcare facilities.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Tests demonstrated 100% sensitivity and 100% specificity in FIND evaluation studies
Product overview1 text field

Arrow Diagnostics distributes molecular diagnostic solutions for microbiology, oncology, genetics, rapid testing, and instrumentation. The product portfolio centers on multiplex Real-Time PCR (Allplex™ and Anyplex™ brands) and isothermal LAMP tests (eazyplex® brand) for syndromic infectious disease detection, covering respiratory infections, gastrointestinal infections, sexually transmitted infections, meningitis, antimicrobial resistance, mycobacteria, HIV, HPV, and fungal diseases. Additional offerings include rapid lateral flow tests (FREND™), fully automated systems (FACIS), Next Generation Sequencing solutions (AD4Seq, CleanPlex®, Deeplex®), oncology diagnostics (MammaTyper®, MYELOID SOLUTION™), and microbiome analysis. The company operates under direction and coordination of Seegene Inc. (Korea) and distributes internationally-developed diagnostic technologies in Italy.

Product and service40 records
1Allplex™ Respiratory Full Panel Assay
CategoryMicrobiology - Respiratory Infections
Description

One-step RT Real-Time PCR multiplex assay for simultaneous detection and identification of 26 respiratory pathogens (16 viruses, 7 bacteria, 3 Flu A subtypes) for clinical microbiology laboratories performing respiratory infection diagnosis.

2Allplex™ Gastrointestinal Full Panel Assay
CategoryMicrobiology - Gastrointestinal Infections
Description

One-step RT Real-Time PCR multiplex assay for simultaneous detection of 25 gastrointestinal pathogens (6 viruses, 13 bacteria, 6 parasites) across 4 diagnostic panels for hospital laboratories diagnosing gastroenteritis.

3Allplex™ STI/BV Panel Assay
CategoryMicrobiology - Sexually Transmitted Infections
Description

Real-Time PCR multiplex assay for simultaneous detection of 28 pathogens (16 bacteria, 7 fungi, 4 viruses, 1 parasite) causing sexually transmitted infections and bacterial vaginosis, targeted at clinical microbiology and STI clinics.

4Anyplex™ II HPV HR Detection
CategoryMicrobiology - HPV / Cervical Cancer Screening
Description

Multiplex Real-Time PCR assay for simultaneous detection of 14 high-risk HPV genotypes (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68) validated for cervical cancer primary screening; CE-IVD marked.

5Anyplex™ II HPV28 Detection
CategoryMicrobiology - HPV / Cervical Cancer Screening
Description

Multiplex Real-Time PCR for simultaneous detection, differentiation, and semiquantification of 28 HPV genotypes (19 high-risk, 9 low-risk) using DPO™ and TOCE™ technologies, for clinical laboratories running HPV genotyping.

6Allplex™ Meningitis Panel Assays
CategoryMicrobiology - Meningitis
Description

One-step RT Real-Time PCR multiplex assay for simultaneous detection and identification of 18 meningitis pathogens (6 bacteria and 12 viruses) for hospital microbiology labs.

7Allplex™ Entero-DR Assay
CategoryMicrobiology - Antimicrobial Resistance
Description

Real-Time PCR multiplex assay for simultaneous detection and identification of 8 antimicrobial resistance genes (carbapenemases, ESBL, AmpC β-lactamases) for clinical microbiology labs performing antimicrobial resistance surveillance.

8Anyplex™ MTB/NTM & Anyplex™ MTB/NTMe Real-Time Detection
CategoryMicrobiology - Mycobacteria
Description

Real-Time PCR assays for detection of Mycobacterium tuberculosis complex and non-tuberculous mycobacteria (NTM), including drug resistance detection variants, for hospital tuberculosis laboratories.

9Allplex™ MG & AziR Assay
CategoryMicrobiology - STI Resistance
Description

Real-Time PCR for detection of Mycoplasma genitalium and macrolide resistance mutations, used by hospital microbiology and STI laboratories.

10Allplex™ MG & MoxiR Assay
CategoryMicrobiology - STI Resistance
Description

Real-Time PCR for detection of Mycoplasma genitalium and fluoroquinolone resistance mutations, for STI and microbiology laboratories.

11HIV-1 Solution v2
CategoryMicrobiology - HIV / Drug Resistance
Description

NGS-based analysis for detection of drug resistance mutations in HIV-1 across RT, protease, integrase, and gp120 regions; IVDR certified under Reg. EU 2017/746, targeted at reference laboratories.

12Goldstream Fungus (1-3)-β-D-Glucan Test
CategoryMicrobiology - Mycology
Description

Chromogenic quantitative detection of (1-3)-β-D-Glucan fungal antigen in serum and bronchoalveolar lavage for diagnosis of invasive fungal infections in hospital laboratories.

13FungiXpert® Aspergillus Galactomannan Detection Kit
CategoryMicrobiology - Mycology
Description

CLIA (chemiluminescence) and LFA tests for rapid detection of Aspergillus galactomannan antigen for invasive aspergillosis diagnosis in hospital microbiology laboratories.

14FungiXpert® Fungus (1-3)-β-D-Glucan Detection Kit
CategoryMicrobiology - Mycology
Description

CLIA-based detection kit for fungal (1-3)-β-D-Glucan antigen for diagnosis of invasive fungal infections.

15GeneProof Aspergillus PCR Kit
CategoryMicrobiology - Mycology
Description

Multiplex Real-Time PCR for simultaneous detection and differentiation of Aspergillus spp and Aspergillus terreus in blood, plasma, BAL, and sputum samples for hospital microbiology laboratories.

16eazyplex® SuperBug CRE
CategoryRapid Tests - Isothermal Amplification
Description

LAMP isothermal rapid test for detection of carbapenemase-producing Enterobacteriaceae (CRE) in approximately 30 minutes without DNA extraction, used by hospital microbiology labs for infection control.

17eazyplex® MRSA/MRSAplus
CategoryRapid Tests - Isothermal Amplification
Description

LAMP isothermal rapid test for detection of methicillin-resistant Staphylococcus aureus (MRSA) including PVL genes in approximately 30 minutes without DNA extraction, for infection control and hospital microbiology use.

18eazyplex® CSF direct
CategoryRapid Tests - Isothermal Amplification
Description

LAMP isothermal rapid test for bacterial and viral meningitis diagnosis in 30 minutes without DNA/RNA extraction, used by hospital laboratories.

19eazyplex® VRE
CategoryRapid Tests - Isothermal Amplification
Description

LAMP isothermal rapid test for vancomycin-resistant Enterococcus (VRE) detection, used for infection control in hospital settings.

20eazyplex® Candida auris
CategoryRapid Tests - Isothermal Amplification
Description

LAMP isothermal rapid test for Candida auris skin colonization detection for hospital infection control and screening programs.

21eazyplex® SARS-CoV-2
CategoryRapid Tests - COVID-19
Description

LAMP isothermal rapid test for SARS-CoV-2 detection for hospital and point-of-care COVID-19 diagnostics.

22eazyplex® Pneumocystis jiroveci
CategoryRapid Tests - Isothermal Amplification
Description

LAMP isothermal rapid test for Pneumocystis jiroveci detection for hospital microbiology laboratories diagnosing PCP pneumonia.

23eazyplex® StrepB
CategoryRapid Tests - Isothermal Amplification
Description

LAMP isothermal rapid test for Streptococcus agalactiae (Group B Strep) detection in less than 30 minutes without DNA extraction, for intrapartum screening in hospitals and maternity wards.

24FREND™ COVID-19 Ag
CategoryRapid Tests - COVID-19
Description

Microfluidic lateral flow immunochromatographic rapid test for qualitative detection of SARS-CoV-2 nucleocapsid antigen in 3 minutes, used by hospitals and event organizers for rapid screening.

25FACIS (Full-Automatic Chemiluminescence Immunoassay System)
CategoryInstrumentation - Automated Immunoassay
Description

Fully automated chemiluminescence immunoassay system for rapid and fully automatic diagnosis of invasive fungal infections in hospital microbiology laboratories.

26AD4Seq
CategoryNGS Microbiology
Description

Next Generation Sequencing (NGS) solution for advanced microbiological diagnostics including comprehensive pathogen identification and genomic analysis for hospital microbiology and reference laboratories.

27CleanPlex® SARS-CoV-2 Panel
CategoryNGS Microbiology
Description

NGS panel for complete genome sequencing of SARS-CoV-2 for research and surveillance use in reference and public health laboratories.

28Deeplex® Myc-TB
CategoryNGS Microbiology
Description

Targeted NGS for comprehensive identification of Mycobacterium tuberculosis complex and non-tuberculous mycobacteria with drug resistance profiling, for hospital and reference TB laboratories.

29Microbiota solution A / Microbiota solution B
CategoryNGS Microbiology
Description

NGS-based bacterial microbiota characterization solutions with automatic result interpretation for clinical and research laboratories.

30MammaTyper®
CategoryOncology
Description

Real-Time PCR-based breast cancer biomarker quantification assay (MammaTyper®) for molecular subtyping of breast cancer in hospital pathology laboratories.

31MYELOID SOLUTION™ BY SOPHiA GENETICS
CategoryOncology
Description

NGS-based solution for myeloid cancer analysis and mutation profiling in myelodysplastic syndromes, used by hospital oncology and reference laboratories.

32Novaplex™ MPXV/OPXV Assay
CategoryMicrobiology - Zoonotic Infections
Description

Multiplex Real-Time PCR assay for simultaneous detection of Monkeypox virus (MPXV) and other orthopoxviruses, used by hospital and reference microbiology laboratories.

33Novaplex™ Tropical fever virus Assay (RUO)
CategoryMicrobiology - Vector-Borne Diseases
Description

Multiplex PCR for detection of tropical fever-causing viruses (Research Use Only) for hospital and reference laboratories.

34Allplex™ GI-Parasite Assay
CategoryMicrobiology - Gastrointestinal Infections
Description

Multiplex Real-Time PCR for diagnosis of intestinal protozoa in stool samples for hospital microbiology laboratories.

35Allplex™ GI-Helminth(I) Assay
CategoryMicrobiology - Gastrointestinal Infections
Description

Multiplex Real-Time PCR for detection of intestinal helminths in stool samples for hospital microbiology laboratories.

36Allplex™ GI-Bacteria(I) Assay
CategoryMicrobiology - Gastrointestinal Infections
Description

Multiplex Real-Time PCR for detection of gastrointestinal bacteria in stool samples for hospital microbiology laboratories.

37Allplex™ RV Essential Assay
CategoryMicrobiology - Respiratory Infections
Description

Real-Time PCR assay for essential respiratory virus detection for hospital clinical laboratories.

38Anyplex™ II STI-7e Detection
CategoryMicrobiology - Sexually Transmitted Infections
Description

Real-Time PCR assay for detection of 7 sexually transmitted infection pathogens for hospital microbiology and STI clinics.

39Allplex™ PneumoBacter Assay
CategoryMicrobiology - Respiratory Infections
Description

Real-Time PCR for detection of Streptococcus pneumoniae and other respiratory bacterial pathogens in hospital microbiology laboratories.

40Allplex™ Dermatophyte Assay (RUO)
CategoryMicrobiology - Mycology
Description

Real-Time PCR assay for dermatophyte detection (Research Use Only) for hospital mycology laboratories.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-10-18
Description

Seegene and Werfen finalized a partnership agreement for a technological sharing initiative. Under the agreement, Seegene and Werfen will establish NewCo Werfen-Seegene in Spain, following completion of required government approvals expected within the first half of 2025. This joint venture represents a significant strategic alliance in the in vitro diagnostics market.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2024-05-23
Description

Seegene and Springer Nature announced a strategic alliance as part of the Open Innovation Program to promote collaboration with researchers working in various fields of medicine using the best PCR diagnostic technologies. This is a flagship initiative under the OneSystem Business model.

3Seegene Inc.
Strategic tierCoreTypeTechnology or Integration
Description

Seegene Inc. (Korea) is the parent company and primary technology provider for Arrow Diagnostics. The company is subject to direction and coordination of Seegene Inc. Arrow Diagnostics distributes Seegene's comprehensive portfolio of multiplex molecular diagnostic products including Allplex, Anyplex, Novaplex, and eazyplex brands in Italy. Seegene provides advanced technologies including DPO (Dual Priming Oligonucleotide) and TOCE (Temperature Oligonucleotide Chip Enumeration) platforms.

arrowdiagnostics.it
4Seegene Inc.
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Arrow Diagnostics operates as the exclusive Italian subsidiary and commercial arm of Seegene Inc. in Italy, coordinating the Open Innovation Program with Springer Nature, participating in the OneSystem Business initiative, and representing Seegene's technological sharing initiatives including the partnership with Werfen.

arrowdiagnostics.it
Strategic tierMajorTypeTechnology or Integration
Description

Illumina is listed as a technology partner providing NGS (Next Generation Sequencing) platforms and technologies that Arrow Diagnostics integrates with its molecular diagnostic solutions, particularly for advanced genomic applications.

Strategic tierMajorTypeTechnology or Integration
Description

Sophia Genetics is a technology partner providing NGS-based solutions including the MYELOID SOLUTION for hematological diagnostics and CleanPlex powered by SOPHiA technology that Arrow Diagnostics distributes in Italy.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global in vitro diagnostics company headquartered in France with strong leadership in clinical microbiology. Comparable as a multinational IVD incumbent whose BioFire multiplex panels and microbiology products directly compete with Arrow's offerings in Italian hospital labs.

TypeBroad incumbent
Description

Italian-headquartered global IVD company (Saluggia) with a broad portfolio spanning immunoassays, molecular diagnostics, and specialty testing. Comparable as a much larger Italian-listed IVD incumbent serving similar clinical laboratory customers, though operating globally with a wider product portfolio.

3Seegene Inc.
TypeOthers
Description

South Korean parent company and primary technology provider for Arrow Diagnostics. Included as the upstream supplier whose product portfolio, R&D pipeline, and strategic decisions (including the Werfen-Seegene NewCo and Microsoft AI collaboration) directly determine Arrow's product roadmap and growth trajectory.

TypeBroad incumbent
Description

Global molecular diagnostics and sample technologies company with a broad PCR and syndromic testing portfolio. Comparable as a major multinational IVD player whose QIAstat-Dx respiratory panel and other molecular products directly overlap with Arrow's syndromic test offerings in Italy.

TypeBroad incumbent
Description

Global molecular diagnostics leader (now part of Danaher) with the GeneXpert system and extensive infectious disease test menu. Comparable as a multinational IVD incumbent whose molecular diagnostic platform directly competes with Arrow's PCR offerings in Italian hospital laboratories.

TypeDirect peer
Description

Italian in vitro diagnostics company headquartered in Padova that manufactures and distributes a wide range of clinical diagnostics products including molecular biology reagents. Comparable as an Italian IVD distributor serving clinical hospital laboratories with a similar product breadth and B2B sales model.

TypeBroad incumbent
Description

Italian-headquartered company (Brescia) specializing in pre-analytical specimen collection and processing, with growing molecular diagnostics capabilities. Comparable as a larger Italian diagnostics player with overlapping clinical laboratory customers in the microbiology workflow.

TypeDirect peer
Description

Italian molecular diagnostics company based in Jesi that develops and distributes real-time PCR kits for pharmacogenetics, oncology, and infectious diseases. Directly comparable as another Italy-based molecular diagnostics distributor with a comparable scale, customer base of clinical laboratories, and product portfolio overlap in infectious disease and oncology.

9GeneticLab
TypeDirect peer
Description

Italian molecular diagnostics company providing PCR and genetic testing services and reagents to Italian clinical laboratories. Comparable as a domestic Italian molecular diagnostics player serving overlapping clinical microbiology and genetics customer segments.

TypeBroad incumbent
Description

Global molecular diagnostics company with the Panther system and broad infectious disease test menu. Comparable as a multinational IVD player with a multiplex molecular diagnostics portfolio directly overlapping Arrow's syndromic panel offerings in Italian hospital labs.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Arrow Diagnostics

Clinical Molecular Diagnosticsarrowdiagnostics.it

Arrow Diagnostics is the exclusive Italian distribution subsidiary of Seegene Inc., selling multiplex PCR kits, isothermal LAMP rapid tests, NGS solutions, and automation to clinical hospital laboratories and public health institutions across Italy.

What Arrow Diagnostics does

Arrow Diagnostics S.r.l. is an Italian molecular diagnostics distribution company headquartered in Genoa, founded in 2003 and operating as a wholly-owned subsidiary subject to the direction and coordination (direzione e coordinamento) of Seegene Inc., a South Korean molecular diagnostics group. The company is the exclusive Italian commercial arm of Seegene, distributing multiplex Real-Time PCR kits (Allplex, Anyplex, Novaplex brands), isothermal LAMP rapid tests (eazyplex), NGS solutions (AD4Seq, CleanPlex, Deeplex), rapid immunochromatographic tests (FREND), and fully automated instrumentation (Seegene STARlet, Seegene Nimbus, FACIS). The portfolio spans syndromic infectious disease testing (respiratory, gastrointestinal, STI, meningitis, antimicrobial resistance, mycobacteria, HPV, mycology), HIV drug resistance NGS, oncology (MammaTyper, MYELOID SOLUTION), and microbiome analysis.

Arrow Diagnostics generates revenue through the B2B sale of molecular diagnostic reagents, kits, and instrumentation to clinical hospital laboratories and public health institutions across Italy, supported by direct field sales coverage of Northern, Central, and Southern Italy and the major islands, plus regional technical representatives and applications support. Products are CE-IVD and IVDR-compliant where certified, with quote-based commercial terms and pricing not publicly disclosed. The company engages customers through scientific congresses (AMCLI, SIM, SIGU), peer-reviewed publications, technical webinars, and an Italian-language website providing IFU, SDS, and SSP documentation. Customer logos include hospital laboratories (e.g., Ospedale A.R.N.A.S. Civico di Cristina Benfratelli di Palermo, MATER OLBIA Hospital) and government/public bodies (ASL1 Imperiese, Lega Navale Italiana), with COVID-era event testing (Sanremo 2021, World Triathlon Cup, HANSA World Championship) representing episodic rather than recurring anchor revenue.

The company's strategic positioning is as a regulatory- and technically-capable local distributor that converts Seegene's global product cadence into Italy-specific clinical adoption, while coordinating Italian participation in parent-level initiatives including the Seegene-Microsoft AI collaboration, the Springer Nature Open Innovation Program, and the Werfen-Seegene technology-sharing JV. No independent venture capital, private equity investment, or public listing has been identified; the entity is fully owned and operated under Seegene's strategic direction.

Arrow Diagnostics firmographics

Firmographics
Name
Arrow Diagnostics
Legal name
Arrow Diagnostics S.r.l.
Website
https://arrowdiagnostics.it
Company type
Private
Founded year
2003
Operating status
Operating
Headcount range
51–100 employees
Short description
Arrow Diagnostics is the exclusive Italian distribution subsidiary of Seegene Inc., selling multiplex PCR kits, isothermal LAMP rapid tests, NGS solutions, and automation to clinical hospital laboratories and public health institutions across Italy.
Ownership category
akta.pro rank

Arrow Diagnostics industry classification

Industry
Product category
Clinical Molecular Diagnostics
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
akta.pro industry
PRIMARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAAALAL
Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)
SECONDARYHLAHAAAA
Clinical Chemistry & Immunoassay Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics

Keywords

  • Molecular diagnostics distribution
  • Multiplex real-time PCR
  • Isothermal amplification tests
  • Clinical microbiology reagents
  • Next generation sequencing kits

Where Arrow Diagnostics is headquartered

Location

Headquarters

HQ city
Genoa
HQ country
Italy
HQ region
Europe

Offices1 record

Markets served

Arrow Diagnostics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Molecular Diagnostic Reagents and Kits: Arrow Diagnostics generates revenue through the sale of molecular diagnostic reagents, PCR kits, and rapid test products to clinical laboratories, hospitals, and healthcare facilities in Italy. Products are sold directly to healthcare institutions with technical support services included.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Arrow Diagnostics product offering

Product offering

Core offering

Arrow Diagnostics distributes and provides technical support for molecular diagnostic reagents, kits, and automated instrumentation in Italy on behalf of Seegene Inc. and other international diagnostic technology partners. Its core offering is a portfolio of multiplex Real-Time PCR assays (Allplex™, Anyplex™, Novaplex™), isothermal LAMP rapid tests (eazyplex®), NGS-based panels (AD4Seq, CleanPlex®, Deeplex®), chemiluminescence immunoassays, and supporting automated systems, sold directly to clinical hospital laboratories, public health labs, and healthcare facilities.

Product overview

Arrow Diagnostics distributes molecular diagnostic solutions for microbiology, oncology, genetics, rapid testing, and instrumentation. The product portfolio centers on multiplex Real-Time PCR (Allplex™ and Anyplex™ brands) and isothermal LAMP tests (eazyplex® brand) for syndromic infectious disease detection, covering respiratory infections, gastrointestinal infections, sexually transmitted infections, meningitis, antimicrobial resistance, mycobacteria, HIV, HPV, and fungal diseases. Additional offerings include rapid lateral flow tests (FREND™), fully automated systems (FACIS), Next Generation Sequencing solutions (AD4Seq, CleanPlex®, Deeplex®), oncology diagnostics (MammaTyper®, MYELOID SOLUTION™), and microbiome analysis. The company operates under direction and coordination of Seegene Inc. (Korea) and distributes internationally-developed diagnostic technologies in Italy.

Differentiator

Problem solved

Functional benefit

Products and services

  • Allplex™ Respiratory Full Panel Assay One-step RT Real-Time PCR multiplex assay for simultaneous detection and identification of 26 respiratory pathogens (16 viruses, 7 bacteria, 3 Flu A subtypes) for clinical microbiology laboratories performing respiratory infection diagnosis.
  • Allplex™ Gastrointestinal Full Panel Assay One-step RT Real-Time PCR multiplex assay for simultaneous detection of 25 gastrointestinal pathogens (6 viruses, 13 bacteria, 6 parasites) across 4 diagnostic panels for hospital laboratories diagnosing gastroenteritis.
  • Allplex™ STI/BV Panel Assay Real-Time PCR multiplex assay for simultaneous detection of 28 pathogens (16 bacteria, 7 fungi, 4 viruses, 1 parasite) causing sexually transmitted infections and bacterial vaginosis, targeted at clinical microbiology and STI clinics.
  • Anyplex™ II HPV HR Detection Multiplex Real-Time PCR assay for simultaneous detection of 14 high-risk HPV genotypes (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68) validated for cervical cancer primary screening; CE-IVD marked.
  • Anyplex™ II HPV28 Detection Multiplex Real-Time PCR for simultaneous detection, differentiation, and semiquantification of 28 HPV genotypes (19 high-risk, 9 low-risk) using DPO™ and TOCE™ technologies, for clinical laboratories running HPV genotyping.
  • Allplex™ Meningitis Panel Assays One-step RT Real-Time PCR multiplex assay for simultaneous detection and identification of 18 meningitis pathogens (6 bacteria and 12 viruses) for hospital microbiology labs.
  • Allplex™ Entero-DR Assay Real-Time PCR multiplex assay for simultaneous detection and identification of 8 antimicrobial resistance genes (carbapenemases, ESBL, AmpC β-lactamases) for clinical microbiology labs performing antimicrobial resistance surveillance.
  • Anyplex™ MTB/NTM & Anyplex™ MTB/NTMe Real-Time Detection Real-Time PCR assays for detection of Mycobacterium tuberculosis complex and non-tuberculous mycobacteria (NTM), including drug resistance detection variants, for hospital tuberculosis laboratories.
  • Allplex™ MG & AziR Assay Real-Time PCR for detection of Mycoplasma genitalium and macrolide resistance mutations, used by hospital microbiology and STI laboratories.
  • Allplex™ MG & MoxiR Assay Real-Time PCR for detection of Mycoplasma genitalium and fluoroquinolone resistance mutations, for STI and microbiology laboratories.
  • HIV-1 Solution v2 NGS-based analysis for detection of drug resistance mutations in HIV-1 across RT, protease, integrase, and gp120 regions; IVDR certified under Reg. EU 2017/746, targeted at reference laboratories.
  • Goldstream Fungus (1-3)-β-D-Glucan Test Chromogenic quantitative detection of (1-3)-β-D-Glucan fungal antigen in serum and bronchoalveolar lavage for diagnosis of invasive fungal infections in hospital laboratories.
  • FungiXpert® Aspergillus Galactomannan Detection Kit CLIA (chemiluminescence) and LFA tests for rapid detection of Aspergillus galactomannan antigen for invasive aspergillosis diagnosis in hospital microbiology laboratories.
  • FungiXpert® Fungus (1-3)-β-D-Glucan Detection Kit CLIA-based detection kit for fungal (1-3)-β-D-Glucan antigen for diagnosis of invasive fungal infections.
  • GeneProof Aspergillus PCR Kit Multiplex Real-Time PCR for simultaneous detection and differentiation of Aspergillus spp and Aspergillus terreus in blood, plasma, BAL, and sputum samples for hospital microbiology laboratories.
  • eazyplex® SuperBug CRE LAMP isothermal rapid test for detection of carbapenemase-producing Enterobacteriaceae (CRE) in approximately 30 minutes without DNA extraction, used by hospital microbiology labs for infection control.
  • eazyplex® MRSA/MRSAplus LAMP isothermal rapid test for detection of methicillin-resistant Staphylococcus aureus (MRSA) including PVL genes in approximately 30 minutes without DNA extraction, for infection control and hospital microbiology use.
  • eazyplex® CSF direct LAMP isothermal rapid test for bacterial and viral meningitis diagnosis in 30 minutes without DNA/RNA extraction, used by hospital laboratories.
  • eazyplex® VRE LAMP isothermal rapid test for vancomycin-resistant Enterococcus (VRE) detection, used for infection control in hospital settings.
  • eazyplex® Candida auris LAMP isothermal rapid test for Candida auris skin colonization detection for hospital infection control and screening programs.
  • eazyplex® SARS-CoV-2 LAMP isothermal rapid test for SARS-CoV-2 detection for hospital and point-of-care COVID-19 diagnostics.
  • eazyplex® Pneumocystis jiroveci LAMP isothermal rapid test for Pneumocystis jiroveci detection for hospital microbiology laboratories diagnosing PCP pneumonia.
  • eazyplex® StrepB LAMP isothermal rapid test for Streptococcus agalactiae (Group B Strep) detection in less than 30 minutes without DNA extraction, for intrapartum screening in hospitals and maternity wards.
  • FREND™ COVID-19 Ag Microfluidic lateral flow immunochromatographic rapid test for qualitative detection of SARS-CoV-2 nucleocapsid antigen in 3 minutes, used by hospitals and event organizers for rapid screening.
  • FACIS (Full-Automatic Chemiluminescence Immunoassay System) Fully automated chemiluminescence immunoassay system for rapid and fully automatic diagnosis of invasive fungal infections in hospital microbiology laboratories.
  • AD4Seq Next Generation Sequencing (NGS) solution for advanced microbiological diagnostics including comprehensive pathogen identification and genomic analysis for hospital microbiology and reference laboratories.
  • CleanPlex® SARS-CoV-2 Panel NGS panel for complete genome sequencing of SARS-CoV-2 for research and surveillance use in reference and public health laboratories.
  • Deeplex® Myc-TB Targeted NGS for comprehensive identification of Mycobacterium tuberculosis complex and non-tuberculous mycobacteria with drug resistance profiling, for hospital and reference TB laboratories.
  • Microbiota solution A / Microbiota solution B NGS-based bacterial microbiota characterization solutions with automatic result interpretation for clinical and research laboratories.
  • MammaTyper® Real-Time PCR-based breast cancer biomarker quantification assay (MammaTyper®) for molecular subtyping of breast cancer in hospital pathology laboratories.
  • MYELOID SOLUTION™ BY SOPHiA GENETICS NGS-based solution for myeloid cancer analysis and mutation profiling in myelodysplastic syndromes, used by hospital oncology and reference laboratories.
  • Novaplex™ MPXV/OPXV Assay Multiplex Real-Time PCR assay for simultaneous detection of Monkeypox virus (MPXV) and other orthopoxviruses, used by hospital and reference microbiology laboratories.
  • Novaplex™ Tropical fever virus Assay (RUO) Multiplex PCR for detection of tropical fever-causing viruses (Research Use Only) for hospital and reference laboratories.
  • Allplex™ GI-Parasite Assay Multiplex Real-Time PCR for diagnosis of intestinal protozoa in stool samples for hospital microbiology laboratories.
  • Allplex™ GI-Helminth(I) Assay Multiplex Real-Time PCR for detection of intestinal helminths in stool samples for hospital microbiology laboratories.
  • Allplex™ GI-Bacteria(I) Assay Multiplex Real-Time PCR for detection of gastrointestinal bacteria in stool samples for hospital microbiology laboratories.
  • Allplex™ RV Essential Assay Real-Time PCR assay for essential respiratory virus detection for hospital clinical laboratories.
  • Anyplex™ II STI-7e Detection Real-Time PCR assay for detection of 7 sexually transmitted infection pathogens for hospital microbiology and STI clinics.
  • Allplex™ PneumoBacter Assay Real-Time PCR for detection of Streptococcus pneumoniae and other respiratory bacterial pathogens in hospital microbiology laboratories.
  • Allplex™ Dermatophyte Assay (RUO) Real-Time PCR assay for dermatophyte detection (Research Use Only) for hospital mycology laboratories.

Quantifiable outcome

  • Tests demonstrated 100% sensitivity and 100% specificity in FIND evaluation studies

Companies that use Arrow Diagnostics

Customer profile

Named customers5 records

Segments2 records

Ideal customer profiles2 records

Arrow Diagnostics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability2 records

Feature4 records

Arrow Diagnostics partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core, flagship and major.

  • WerfencoreStrategic or Co-development Partner · 18 October 2024Seegene and Werfen finalized a partnership agreement for a technological sharing initiative. Under the agreement, Seegene and Werfen will establish NewCo Werfen-Seegene in Spain, following completion of required government approvals expected within the first half of 2025. This joint venture represents a significant strategic alliance in the in vitro diagnostics market.
  • Springer NatureflagshipStrategic or Co-development Partner · 23 May 2024Seegene and Springer Nature announced a strategic alliance as part of the Open Innovation Program to promote collaboration with researchers working in various fields of medicine using the best PCR diagnostic technologies. This is a flagship initiative under the OneSystem Business model.
  • Seegene Inc.coreTechnology or IntegrationSeegene Inc. (Korea) is the parent company and primary technology provider for Arrow Diagnostics. The company is subject to direction and coordination of Seegene Inc. Arrow Diagnostics distributes Seegene's comprehensive portfolio of multiplex molecular diagnostic products including Allplex, Anyplex, Novaplex, and eazyplex brands in Italy. Seegene provides advanced technologies including DPO (Dual Priming Oligonucleotide) and TOCE (Temperature Oligonucleotide Chip Enumeration) platforms.
  • Seegene Inc.coreStrategic or Co-development PartnerArrow Diagnostics operates as the exclusive Italian subsidiary and commercial arm of Seegene Inc. in Italy, coordinating the Open Innovation Program with Springer Nature, participating in the OneSystem Business initiative, and representing Seegene's technological sharing initiatives including the partnership with Werfen.
  • IlluminamajorTechnology or IntegrationIllumina is listed as a technology partner providing NGS (Next Generation Sequencing) platforms and technologies that Arrow Diagnostics integrates with its molecular diagnostic solutions, particularly for advanced genomic applications.
  • Sophia GeneticsmajorTechnology or IntegrationSophia Genetics is a technology partner providing NGS-based solutions including the MYELOID SOLUTION for hematological diagnostics and CleanPlex powered by SOPHiA technology that Arrow Diagnostics distributes in Italy.

Scale indicators2 records

Recent moves6 records

Expansion highlights7 records

Arrow Diagnostics competitors and assessment

Company assessment

Broad incumbents

  • bioMérieux: Global in vitro diagnostics company headquartered in France with strong leadership in clinical microbiology. Comparable as a multinational IVD incumbent whose BioFire multiplex panels and microbiology products directly compete with Arrow's offerings in Italian hospital labs.
  • DiaSorin: Italian-headquartered global IVD company (Saluggia) with a broad portfolio spanning immunoassays, molecular diagnostics, and specialty testing. Comparable as a much larger Italian-listed IVD incumbent serving similar clinical laboratory customers, though operating globally with a wider product portfolio.
  • QIAGEN: Global molecular diagnostics and sample technologies company with a broad PCR and syndromic testing portfolio. Comparable as a major multinational IVD player whose QIAstat-Dx respiratory panel and other molecular products directly overlap with Arrow's syndromic test offerings in Italy.
  • Cepheid (Danaher): Global molecular diagnostics leader (now part of Danaher) with the GeneXpert system and extensive infectious disease test menu. Comparable as a multinational IVD incumbent whose molecular diagnostic platform directly competes with Arrow's PCR offerings in Italian hospital laboratories.
  • Copan Diagnostics: Italian-headquartered company (Brescia) specializing in pre-analytical specimen collection and processing, with growing molecular diagnostics capabilities. Comparable as a larger Italian diagnostics player with overlapping clinical laboratory customers in the microbiology workflow.
  • Hologic: Global molecular diagnostics company with the Panther system and broad infectious disease test menu. Comparable as a multinational IVD player with a multiplex molecular diagnostics portfolio directly overlapping Arrow's syndromic panel offerings in Italian hospital labs.

Others

  • Seegene Inc. South Korean parent company and primary technology provider for Arrow Diagnostics. Included as the upstream supplier whose product portfolio, R&D pipeline, and strategic decisions (including the Werfen-Seegene NewCo and Microsoft AI collaboration) directly determine Arrow's product roadmap and growth trajectory.

Direct peers

  • AB Analitica: Italian in vitro diagnostics company headquartered in Padova that manufactures and distributes a wide range of clinical diagnostics products including molecular biology reagents. Comparable as an Italian IVD distributor serving clinical hospital laboratories with a similar product breadth and B2B sales model.
  • Diatech Pharmacogenetics: Italian molecular diagnostics company based in Jesi that develops and distributes real-time PCR kits for pharmacogenetics, oncology, and infectious diseases. Directly comparable as another Italy-based molecular diagnostics distributor with a comparable scale, customer base of clinical laboratories, and product portfolio overlap in infectious disease and oncology.
  • GeneticLab: Italian molecular diagnostics company providing PCR and genetic testing services and reagents to Italian clinical laboratories. Comparable as a domestic Italian molecular diagnostics player serving overlapping clinical microbiology and genetics customer segments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Arrow Diagnostics compliance and trust

Trust signal

Compliance2 records

Arrow Diagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Arrow Diagnostics leadership team

Management profile

Number of profiles

Arrow Diagnostics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Arrow Diagnostics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Arrow Diagnostics

What does Arrow Diagnostics do?

Arrow Diagnostics distributes and provides technical support for molecular diagnostic reagents, kits, and automated instrumentation in Italy on behalf of Seegene Inc. and other international diagnostic technology partners. Its core offering is a portfolio of multiplex Real-Time PCR assays (Allplex™, Anyplex™, Novaplex™), isothermal LAMP rapid tests (eazyplex®), NGS-based panels (AD4Seq, CleanPlex®, Deeplex®), chemiluminescence immunoassays, and supporting automated systems, sold directly to clinical hospital laboratories, public health labs, and healthcare facilities.

Is Arrow Diagnostics a public or private company?

Arrow Diagnostics is a private company. It is classified as corporate owned and is currently operating.

When was Arrow Diagnostics founded?

Arrow Diagnostics was founded in 2003. It employs 51 to 100 people.

Where is Arrow Diagnostics based?

Arrow Diagnostics is headquartered in Genoa, Italy, in the Europe region.

How does Arrow Diagnostics make money?

One revenue line is on record: molecular Diagnostic Reagents and Kits.

Who are Arrow Diagnostics's main competitors?

Broad incumbents on record are bioMérieux, DiaSorin, QIAGEN, Cepheid (Danaher), Copan Diagnostics and Hologic. Seegene Inc. is listed as an others. Direct peers are AB Analitica, Diatech Pharmacogenetics and GeneticLab.

Does Arrow Diagnostics have an API?

No public API is recorded for Arrow Diagnostics.

What industry is Arrow Diagnostics in?

Arrow Diagnostics's product category is Clinical Molecular Diagnostics. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAAALAL, Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals